PEDIATRICS Vol. 118 No. 2 August 2006, pp. 753-757 (doi:10.1542/peds.2006-0737)
SPECIAL ARTICLE |
Summary of Consensus Statement on Intersex Disorders and Their Management
a Department of Pediatrics, Backus Children’s Hospital, Mercer University School of Medicine, Savannah, Georgia
b Department of Paediatrics, University of Cambridge, Addenbrooke’s Hospital, Cambridge, United Kingdom
c Co-chairs
d Department of Child Health, Royal Hospital for Sick Children, Glasgow, Scotland, United Kingdom
e Department of Pediatrics, Penn State College of Medicine, Milton S. Hershey Medical Center, Hershey, Pennsylvania
Key Words: intersex • sexual differentiation • ambiguous genitalia • genital surgery
Abbreviations: DSD—disorder(s) of sex development • AE—androgen exposure • CAH—congenital adrenal hyperplasia • 5
-RD2—5-reductase deficiency • CAIS—complete androgen insensitivity syndrome
Advances in understanding of genetic control of sexual determination and differentiation, improvements in diagnostic testing and surgical genital repair, and the persistent controversies inherent to clinical management were all compelling factors that led to the organization of an international consensus conference. The goals were to acknowledge and discuss the more controversial issues in intersex management, provide management guidelines for intersex patients, and identify and prioritize questions that need additional investigation. This is a summary statement.
 |
NOMENCLATURE AND DEFINITIONS |
|---|
 TOP NOMENCLATURE AND DEFINITIONS BACKGROUND INFORMATIONEVALUATIONMANAGEMENTINTERNATIONAL INTERSEX CONSENSUS...REFERENCES |
|---|
Advances in molecular genetic causes of abnormal sexual development and heightened awareness of the ethical and patient-advocacy issues mandate reexamination of existing nomenclature for patients with intersex.1 Terminology such as "pseudohermaphroditism" is controversial, potentially pejorative to patients,2 and inherently confusing. Therefore, the term "disorders of sex development" (DSD) is proposed to indicate congenital conditions with atypical development of chromosomal, gonadal, or anatomic sex.
Additional rationale for new classification is the need for modern categorization to integrate the modern molecular genetic aspects, to maximize precision when applying definitions and diagnostic labels,3 and to meet the need for psychologically sensitive yet descriptive medical terminology. Nomenclature should be flexible enough to incorporate new information, robust enough to maintain a consistent framework, use descriptive terms, reflect genetic etiology, accommodate phenotypic variation spectrum, and be useful for clinicians, scientists, patients, and families. Hence, we propose a new classification (see "Consensus Statement on Management of Intersex Disorders"4 in this month's issue of Pediatrics Electronic Edition).
Three traditionally conceptualized domains of psychosexual development are gender identity (one's self-representation [ie, male or female]), gender role (sexually dimorphic behaviors within the general population, such as toy preferences, aggression, and spatial ability), and sexual orientation (direction[s] of erotic interest). Gender dissatisfaction denotes unhappiness with assigned sex and may result in gender self-reassignment. Psychosexual developmental factors relate to parental psychopathology, parent-child attachment, or parenting practices (eg, not discouraging cross-sex behavior). Dissatisfaction occurs more frequently in individuals with DSD than the general population, is not predictable by karyotype, androgen exposure (AE), degree of genital virilization, or assigned sex,5 and has not been well studied with regard to social, personal, or biological factors.
|
BACKGROUND INFORMATION |
|---|
|
TOPNOMENCLATURE AND DEFINITIONSBACKGROUND INFORMATIONEVALUATIONMANAGEMENTINTERNATIONAL INTERSEX CONSENSUS...REFERENCES |
|---|
Psychosexual development is influenced by multiple factors including sex-chromosome genes, brain structure, social circumstance, family dynamics, and prenatal AE.6 AE is apparently dose related7 (eg, childhood play behaviors in girls with congenital adrenal hyperplasia [CAH]) and associated with development of male gender identity (patients with 46,XY cloacal exstrophy who were gonadectomized neonatally). Androgen effect on genital development apparently occurs independently of effect on neural and behavioral development; genital appearance does not predict gender-role change. Outcome cannot be predicted by degree of prenatal AE for any DSD, with variability relating to both prenatal and postnatal AE differences (eg, 5
-reductase deficiency [5-RD2]). Emerging evidence suggests direct effects of sex-chromosome genes on brain and behavior,8 but behavioral roles for Y-chromosome genes have not been identified.9 A Y-chromosome and male-typical prenatal AE does not unequivocally entrain adult male gender identity.10
Sex differences in brain structures have been identified across species.11 Human postmortem and neuroimaging studies have found that male brains are 8% to 10% larger than female brains. Sexual dimorphism in specific neural subcomponents persists after adjustment for brain size. The limbic system and hypothalamus are important because of roles in reproduction; specific nuclei show sexual dimorphism on postmortem studies (bed nucleus of the stria terminalis, suprachiasmatic nucleus, and the interstitial nucleus of the anterior hypothalamus 3), although it is unknown when these differences emerge. Relationships between structural brain differences and psychosexual development are unclear.
DSD may carry stigma. Environmental and cultural factors influence gender role (gender-change frequency differences in 5-RD2 deficiency in different counties). Religious, philosophical, fatalism, or guilt viewpoints influence parents' actions. In some societies, female infertility precludes marriage, employment prospects, and economic independence. Poverty impairs access to health care.12
Standard-of-care concepts for best clinical management of DSD13 include a gender assignment for all; avoiding gender assignment before expert evaluation in newborns; open communication; multidisciplinary-team evaluation and management; family/patient participation in decision-making; respect and attention to patient/family concerns; and strict confidentiality.
Key points to address during the crucial initial parental contact include: children with DSD have the potential to become well-adjusted persons; DSD is not shameful, but privacy is respected; and although the best course of action may not be obvious, caregivers with parents arrive at the best possible decisions.
A core team ideally includes pediatric endocrinologists, surgeons, urologists or gynecologists, psychologists/psychiatrists, geneticists, neonatologists, social workers, nurses, and medical ethicists14 with communication with the primary care physician.15 Consensus regarding diagnosis, gender assignment, and treatment options must be reached before making recommendations, with one team member primarily interacting with the family.16 The surgeon's role involves outlining surgical sequences and consequences of aligning genitalia for assigned gender, establishing functional genital anatomy, and, if indicated, timely gonadectomy. Support groups can play a positive role.17
|
EVALUATION |
|---|
|
TOPNOMENCLATURE AND DEFINITIONSBACKGROUND INFORMATIONEVALUATIONMANAGEMENTINTERNATIONAL INTERSEX CONSENSUS...REFERENCES |
|---|
Criteria suggesting DSD include overt genital ambiguity; apparent female genitalia (enlarged clitoris, posterior labial fusion, inguinal/labial mass); apparent male genitalia (nonpalpable testes, micropenis, isolated perineal hypospadias, or mild hypospadias with undescended testis); a family history of DSD (eg, complete androgen insensitivity syndrome [CAIS]); and genital and karyotype discordance.
DSD in older individuals may include unrecognized genital ambiguity, inguinal hernia in a female, delayed/incomplete puberty, virilization in a female, primary amenorrhea, male breast development, and gross hematuria in a male.
Clinical evaluation includes family and prenatal history and physical examination with an accurate and objective assessment of genitalia and any dysmorphic features. To minimize psychological distress, the patient/family should be informed exactly what will be done and why. Medical photography requires sensitivity and consent.18
A specific molecular diagnosis is identified in only 
20% of gonadal differentiation defects.19 Most virilized 46,XX infants have CAH; only 50% of undervirilized 46,XY patients receive a definitive diagnosis.20,21 Given the spectrum of findings and diagnoses, no specific single evaluation protocol can be used. Plasma hormone concentrations must be interpreted using normal ranges for gestational and chronological age for the assay used.
In newborns, first-line testing includes karyotyping with SRY detection (even when prenatal karyotype is available), imaging (abdominopelvic ultrasound), and measurement of 17-hydroxyprogesterone, testosterone, gonadotropins, anti-Mullerian hormone, and electrolytes. Usually, results that are sufficient for diagnosis should be available within 48 hours. Although cases must be individualized, practical decision-making algorithms are available22 to guide additional investigation. Although mutations in established genes may be readily identified by clinical laboratories, current molecular diagnosis is limited by cost, accessibility, quality control, and inadequate functional interpretation.23
|
MANAGEMENT |
|---|
|
TOPNOMENCLATURE AND DEFINITIONSBACKGROUND INFORMATIONEVALUATIONMANAGEMENTINTERNATIONAL INTERSEX CONSENSUS...REFERENCES |
|---|
Newborn Gender Assignment
Outcome data indicate that >90% of patients with 46,XX CAH and all patients with 46,XY CAIS who are assigned female sex in infancy identify as females. Two thirds of patients with 5
-RD2 who were initially assigned female sex who virilize at puberty, and all who were assigned male, live as males. Gender-role changes are reported for approximately half of the 17ß-hydroxysteroid dehydrogenase-3-deficient patients who are raised as girls. The recommendations are to raise infants with 46,XY CAIS and 46,XX CAH as females, whereas for infants diagnosed with 5-RD2 or 17ß-hydroxysteroid dehydrogenase-3 deficiency, a male assignment should be considered.24
Sexual functioning, psychosocial adjustment, mental health, quality of life, and social participation are understudied. Attention has been toward dissatisfaction with assigned sex or gender self-reassignment. Dissatisfaction is found in 25% of 46,XY patients with partial virilization regardless of assigned gender.25 Data support male rearing in most XY infants with significant phallic tissue and all with micropenis.26 Assignment for patients with ovotesticular DSD must consider fertility potential assuming consistent genitalia. In the child with mixed gonadal dysgenesis, AE, phallic size, gonadal function, and location are considered. Outcome data for 46,XY child with cloacal exstrophy are conflicting precluding clear assignment recommendations. Hence, decisions should be made with the families' full input and consent after they know the potential risks and benefits and potential impact of options. Available evidence-based data concerning fertility potential and surgical procedures must be provided.
Assignment should be made as quickly as thorough diagnostic evaluation permits. Influencing factors include diagnosis, genital appearance, therapeutic options, fertility potential, cultural practices and pressures, and parental views. Individual DSD outcome data regarding gender identity, quality of life, avoidance of unnecessary surgery, hormone replacement, and fertility preservation must be considered. Fertility-potential considerations include expected fertility in virilized females with a well-developed uterus and ovaries, unlikely fertility in undermasculinized males without assisted-reproduction techniques, and fertility in some patients with ovotesticular DSD. Appearance-altering surgery is not urgent. Somatosexual and psychosexual differentiation information and treatment options are needed. Balanced, technologically sound, Web-based information may be helpful.27 Ample time should be provided for discussion, repeating information, and reassessment of understanding. To assist parents in coping, information to be shared with siblings and others should be discussed.
Surgery
Rationale for early reconstruction28 includes beneficial effects of estrogen on infant tissues, avoiding complications from anatomic anomalies, satisfactory outcomes,29 minimizing family concern and distress,30 and mitigating the risks of stigmatization and gender-identity confusion of atypical genital appearance. Adverse outcomes have led to recommendations to delay unnecessary genital surgery to an age of patient informed consent, although relative risks and benefits are unknown. Age-specific preparatory procedures including coping-skill training and behavior-therapy techniques are psychologically beneficial.31 The goals of genital surgery are to maximize anatomy to enhance sexual function and romantic partnering.
Feminizing genital surgery involves external genitalia reconstruction and vaginal exteriorization, with early separation of the vagina and urethra.32 Clitoral reduction is considered with severe virilization and performed in conjunction with common urogenital sinus repair. Vaginal dilatation should not be performed during childhood. Refinement is generally necessary at puberty.33 Procedures should emphasize functional cosmetic appearance and be designed to preserve erectile function and enervation. Vaginoplasty should be performed in the teenage years; each of the techniques (self-dilatation, skin or bowel substitution) has specific advantages and disadvantages,34 and all carry potential for scarring that would require modification before sexual function.35
Masculinizing genital surgery involves more surgical procedures and urologic difficulties than feminizing genitoplasty. Standard surgical repair involving hypospadias includes chordee correction, urethral reconstruction, and judicious testosterone supplementation.36 If needed, adult-sized testicular prostheses should be inserted after sufficient pubertal scrotal development. The enormity of the undertaking and complexity of phalloplasty must be considered during the initial counseling period.37 Care should be taken to avoid unrealistic expectations about penile reconstruction.
Germ cell malignancy only occurs in patients with DSD who have Y-chromosomal material (GBY region). The highest risk (up to 60%) is found in patients with DSD with GBY-positive gonadal dysgenesis and partial androgen insensitivity syndrome with intraabdominal gonads. The lowest risk (<5%) is found in ovotestis38 and genetically confirmed CAIS. Intraabdominal gonads of high-risk patients (gonadal dysgenesis plus GBY and partial androgen insensitivity syndrome) should be removed at diagnosis. Gonadectomy of streak gonads should be performed in childhood in mixed gonadal dysgenesis and in females with gonadal dysgenesis and Y-chromosome material. Patients with DSD, raised as males with scrotal gonads, should have a gonadal biopsy at puberty.39
Gender Reassignment
Gender reassignment, which should always be initiated by the patient, should be approached very cautiously. Because childhood gender dissatisfaction may remit, the key challenge is to identify multiple determinants of gender identity, additional biological factors, social factors (especially parent characteristics, family functioning, peer relationships), and personal characteristics. Discordant gender-role behavior, which is more common in children with DSD, should not be considered an indication for gender reassignment, because sex-typical behavior, sexual orientation, and gender identity should be considered separately. Homosexual orientation (relative to sex of rearing) or strong cross-sex interest in an individual with DSD is not an indication of incorrect sex assignment. In patients with DSD who have significant gender dysphoria, a comprehensive psychological evaluation40 and extensive parental discussion is required. A patient with persistent desire for gender change should be referred to a skilled specialist.
If needed, timing of the pubertal induction should be individualized. Hormone effects, reproduction, sexuality, and the patient's expectations should be discussed. Sex-steroid replacement induces pubertal changes, growth, and bone mineralization and provides for psychosocial and psychosexual maturation.41 Androgens for males include testosterone esters (oral [testosterone undecanoate] and transdermal preparations). Females with hypogonadism require estrogen supplementation followed by progestin breakthrough bleeding (unneeded if the uterus is absent).
Data on fertility are limited for most DSD. Females with an adequately formed uterus and males with evidence of functional seminiferous tubules may have fertility potential with assisted-reproduction techniques.
Psychosocial management with a practitioner who has expertise in sexuality is integral for patients with DSD to promote positive adaptation. Specialized psychosocial assessment can guide team decisions about gender assignment/reassignment, timing of surgery, and sex-hormone replacement. Coping should be evaluated in the context of overall vulnerability (developmental history, temperamental characteristics, cognitive level, family and social environment).42 Psychological issues to be addressed include sexuality, fertility, culture, and social circumstances. The most frequent sexual problems in patients with DSD are avoidance of intimacy, sexual aversion, and lack of arousability, often misinterpreted as low libido.43 The process of relationship-building includes informing a partner about one's condition, addressing fears of rejection, and focusing on relationships rather than solely on sexual function and activity.
Disclosure of salient and sensitive aspects of the patient's condition (karyotype, gonadal status, fertility) are integral parts of patient care and a flexible individual-based approach. Disclosure should be planned with parents for ongoing dialogue.44 Generally, disclosure is associated with enhanced psychosocial adaptation,45 but it may not always be helpful.
|
INTERNATIONAL INTERSEX CONSENSUS CONFERENCE PARTICIPANTS |
|---|
|
TOPNOMENCLATURE AND DEFINITIONSBACKGROUND INFORMATIONEVALUATIONMANAGEMENTINTERNATIONAL INTERSEX CONSENSUS...REFERENCES |
|---|
Olaf Hiort (Lübeck, Germany), Eric Vilain (Los Angeles, CA), Melissa Hines (London, UK), Sheri Berenbaum (University Park, PA), Copeland, Ken (Oklahoma City, OK), Patricia Donohoue (Iowa City, IA), Laurence Baskin (San Francisco, CA), Pierre Mouriquand (Lyon, France), Heino Meyer-Bahlburg (New York, NY), Polly Carmichael (London, UK), Stenvert Drop (Rotterdam, Netherlands), Garry Warne (Melbourne, Australia) John Achermann (London, UK), Erica Eugster (Indianapolis, IN), Vincent Harley (Victoria, Australia), Yves Morel (Lyon, France), Robert Rapaport (New York, NY), Jean Wilson (Dallas, TX), Peggy Cohen-Kettenis (Amsterdam, Netherlands), Jay Giedd (Bethesda, MD), Anna Nordenström (Stockholm, Sweden), William Reiner (Oklahoma City, OK), Emilie Rissman (Charlottesville, VA), Sylvano Bertelloni (Pisa, Italy), Felix Conte (San Francisco, CA), Claude Migeon (Baltimore, MD), Chris Driver (Aberdeen, UK), Kenji Fujieda (Asahikawa, Japan), John Brock (Nashville, TN), Melvin Grumbach (San Francisco, CA), Phillip Ransley (London, UK), Richard Rink (Indianapolis, IN, Christopher Woodhouse (London, UK), Hertha Richter-Appelt (Hamburg, Germany), David Sandberg (Buffalo, NY), Norman Spack (Boston, MA), Barbara Thomas (Rottenburg am Neckar, Germany), Kenneth Zucker (Toronto, Ontario, Canada), Leendert Looijenga (Rotterdam, Netherlands), Bernadice Mendoca (Sao Paulo, Brazil), Paul Saenger (New York, NY), Justine Schober (Erie, PA), Ute Thyen (Lübeck, Germany), Amy Wisniewski (Des Moines, IA), and Cheryl Chase (Rohnert Park, CA).
|
FOOTNOTES |
|---|
Accepted Mar 22, 2006.
Address correspondence to Peter A. Lee, MD, PhD, Department of Pediatrics, MC-H085, Penn State College of Medicine, Milton S. Hershey Medical Center, Box 850, 500 University Dr, Hershey, PA 17033-0850. E-mail: plee{at}psu.edu
The authors have indicated they have no financial relationships relevant to this article to disclose.
|
REFERENCES |
|---|
|
TOPNOMENCLATURE AND DEFINITIONSBACKGROUND INFORMATIONEVALUATIONMANAGEMENTINTERNATIONAL INTERSEX CONSENSUS...REFERENCES |
|---|
1. Frader J, Alderson P, Asch A, et al. Health care professionals and intersex conditions. Arch Pediatr Adolesc Med. 2004;158 :426 –429
2. Conn J, Gillam L, Conway G. Revealing the diagnosis of androgen insensitivity syndrome in adulthood.
BMJ. 2005;331
:628
–630
3. Dreger AD, Chase C, Sousa A, Grupposo PA, Frader J. Changing the nomenclature/taxonomy for intersex: a scientific and clinical rationale. J Pediatr Endocrinol Metab. 2005;18 :729 –733[Web of Science][Medline]
4. Lee PA, Houk CP, Ahmed SF, Hughes IA. Consensus statement on management of intersex disorders. Pediatrics. 2006;118 (2). Available at: www.pediatrics.org/cgi/content/full/118/2/e488
5. Zucker KJ. Intersexuality and gender identity differentiation. Annu Rev Sex Res. 1999;10 :1 –69[Medline]
6. Cohen-Bendahan CCC, van de Beek C, Berenbaum SA. Prenatal sex hormone effects on child and adult sex-typed behavior: methods and findings. Neurosci Biobehav Rev. 2005;29 :353 –384[CrossRef][Web of Science][Medline]
7. Nordenström A, Servin A, Bohlin G, Larsson A, Wedell A. Sex-typed toy play behavior correlates with the degree of prenatal androgen exposure assessed by CYP21 genotype in girls with congenital adrenal hyperplasia.
J Clin Endocrinol Metab. 2002;87
:5119
–5124
8. De Vries GJ, Rissman EF, Simerly RB, et al. A model system for study of sex chromosome effects on sexually dimorphic neural and behavioral traits.
J Neurosci. 2002;22
:9005
–9014
9. Hines M, Ahmed F, Hughes IA. Psychological outcomes and gender-related development in complete androgen insensitivity syndrome. Arch Sex Behav. 2003;32 :93 –101[CrossRef][Web of Science][Medline]
10. Meyer-Bahlburg HF. Gender identity outcome in female-raised 46,XY persons with penile agenesis, cloacal exstrophy of the bladder, or penile ablation. Arch Sex Behav. 2005;34 :423 –438[CrossRef][Web of Science][Medline]
11. Paus T. Mapping brain maturation and cognitive development during adolescence. Trends Cogn Sci. 2005;9 :60 –68[CrossRef][Web of Science][Medline]
12. Warne GL, Bhatia V. Intersex, East and West. In: Sytsma S, ed. Ethics and Intersex. Heidelburg, Germany: Springer; 2006:183–205
13. Consortium on the Management of Disorders of Sex Differentiation. Clinical guidelines for the management of disorders of sex development in childhood. Available at: www.dsdguidelines.org/htdocs/clinical/index.html. Accessed June 7, 2006
14. Lee PA. A perspective on the approach to the intersex child born with genital ambiguity. J Pediatr Endocrinol Metab. 2004;17 :133 –140[Web of Science][Medline]
15. American Academy of Pediatrics, Council on Children With Disabilities. Care coordination in the medical home: integrating health and related systems of care for children with special health care needs.
Pediatrics. 2005;116
:1238
–1244
16. Cashman S, Reidy P, Cody K, Lemay C. Developing and measuring progress toward collaborative, integrated, interdisciplinary health teams. J Interprof Care. 2004;18 :183 –196[CrossRef][Medline]
17. Warne G. Support groups for CAH and AIS. Endocrinologist. 2003;13 :175 –178
18. Creighton S, Alderson J, Brown S, Minto CL. Medical photography: ethics, consent and the intersex patient. BJU Int. 2002;89 :67 –71[Web of Science][Medline]
19. MacLaughlin DL, Donahoe PK. Sex determination and differentiation [published correction appears in N Engl J Med. 2004;351:306].
N Engl J Med. 2004;350
:367
–378
20. Ahmed SF, Cheng A, Dovey L, et al. Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome.
J Clin Endocrinol Metab. 2000;85
:658
–665
21. Morel Y, Rey R, Teinturier C, et al. Aetiological diagnosis of male sex ambiguity: a collaborative study. Eur J Pediatr. 2002;161 :49 –59[Web of Science][Medline]
22. Nicolino M, Bendelac N, Jay N, Forest MG, David M. Clinical and biological assessments of the undervirilized male. BJU Int. 2004;93 (suppl 3):20 –25
23. Quillin JM, Jackson-Cook C, Bodurtha J. The link between providers and patients: how laboratories can ensure quality results with genetic testing. Clin Leadersh Manag Rev. 2003;17 :351 –357[Medline]
24. Mendonca BB, Inacio M, Costa EMF, et al. Male pseudohermaphroditism due to 5 alpha-reductase 2 deficiency: outcome of a Brazilian Cohort. Endocrinologist. 2003;13 :202 –204
25. Migeon CJ, Wisniewski AB, Gearhart JP, et al. Ambiguous genitalia with perineoscrotal hypospadias in 46,XY individuals: long-term medical, surgical, and psychosexual outcome. Pediatrics. 2002 Sep;110(3) . Available at: www.pediatrics.org/cgi/content/full/110/3/e31
26. Mazur T. Gender dysphoria and gender change in androgen insensitivity or micropenis. Arch Sex Behav. 2005;34 :411 –421[CrossRef][Web of Science][Medline]
27. SickKids. Child physiology: how the body works. Available at: www.sickkids.ca/childphysiology/cpwp/genital/genitalintro.htm. Accessed June 7, 2006
28. American Academy of Pediatrics, Section on Urology. Timing of elective surgery on the genitalia of male children with particular reference to the risks, benefits, and psychological effects of surgery and anesthesia.
Pediatrics 1996;97
:590
–594
29. Warne G, Grover S, Hutson J, et al. A long-term outcome study of intersex conditions. J Pediatr Endocrinol Metab. 2005;18 :555 –567[Web of Science][Medline]
30. Crouch NS, Minto CL, Laio LM, Woodhouse CR, Creighton SM. Genital sensation after feminizing genitoplasty for congenital adrenal hyperplasia: a pilot study. BJU Int. 2004;93 :135 –138[CrossRef][Web of Science][Medline]
31. Harbeck-Weber C, Fisher JL, Dittner CA. Promoting coping and enhancing adaptation to illness. In: Roberts MC, ed. Handbook of Pediatric Psychology. 3rd ed. New York, NY: Guilford Press; 2003:99–118
32. Meyer-Bahlburg HF, Migeon CJ, Berkovitz GD, et al. Attitudes of adult 46,XY intersex persons to clinical management policies. J Urol. 2004;171 :1615 –1619[CrossRef][Web of Science][Medline]
33. Eroglu E, Tekant G, Gundogdu G, et al. Feminizing surgical management of intersex patients. Pediatr Surg Int. 2004;20 :543 –547[Web of Science][Medline]
34. Schober JM. Long-term outcomes of feminizing genitoplasty for intersex. In: Pediatric Surgery and Urology: Long-term Outcomes. London, United Kingdom: WB Saunders; In press
35. Creighton SM. Long-term outcome of feminization surgery: the London experience. BJU Int. 2004;93(suppl 3) :44 –46[CrossRef]
36. Mouriquand PD, Mure PY. Current concepts in hypospadiology. BJU Int. 2004;93 (suppl 3):26 –34
37. Bettocchi C, Ralph DJ, Pryor JP. Pedicled phalloplasty in females with gender dysphoria. BJU Int. 2005;95 :120 –124[CrossRef][Web of Science][Medline]
38. Ramani P, Yeung CK, Habeebu SS. Testicular intratubular germ cell neoplasia in children and adults with intersex. Am J Surg Pathol. 1993;17 :1124 –1133[Web of Science][Medline]
39. Woodward PJ, Heidenriech A, Looijenga LHJ, et al. World Health Organization classification of tumours. In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA, eds. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon, France: ARC Press; 2004:217 –278
40. Zucker KJ. Measurement of psychosexual differentiation. Arch Sex Behav. 2005;34 :375 –388[CrossRef][Web of Science][Medline]
41. Warne GL, Grover S, Zajac JD. Hormonal therapies for individuals with intersex conditions: protocol for use. Treat Endocrinol. 2005;4 :19 –29[CrossRef][Medline]
42. Kazak AE, Rourke MT, Crump TA. Families and other systems in pediatric psychology. In: Roberts MC, ed. Handbook of Pediatric Psychology. 3rd ed. New York, NY: Guilford Press; 2003:159–175
43. Basson R, Leiblum S, Brotto L, et al. Definitions of women's sexual dysfunction reconsidered: advocating expansion and revision. J Psychosom Obstet Gynaecol. 2003;24 :221 –229[Medline]
44. Carmichael P, Ransley P. Telling children about a physical intersex condition. Dialogues Pediatr Urol. 2002;25 :7 –8
45. American Academy of Pediatrics, Committee on Pediatrics AIDS. Disclosure of illness status to children and adolescents with HIV infection.
Pediatrics. 1999;103
:164
–166
PEDIATRICS (ISSN 1098-4275). ©2006 by the American Academy of Pediatrics
CiteULike 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  G. B. Chavhan, D. A. Parra, K. Oudjhane, S. F. Miller, P. S. Babyn, and F. L. Pippi Salle Imaging of Ambiguous Genitalia: Classification and Diagnostic Approach1 RadioGraphics, November 1, 2008; 28(7): 1891 - 1904. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Nordenskjold, G. Holmdahl, L. Frisen, H. Falhammar, H. Filipsson, M. Thoren, P. O. Janson, and K. Hagenfeldt Type of Mutation and Surgical Procedure Affect Long-Term Quality of Life for Women with Congenital Adrenal Hyperplasia J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 380 - 386. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. T. Maciel-Guerra, M. P. de Mello, F. B. Coeli, M. L. Ribeiro, M. L. Miranda, A. P. Marques-de-Faria, M. T. M. Baptista, S. G. Moraes, and G. Guerra-Junior XX Maleness and XX True Hermaphroditism in SRY-Negative Monozygotic Twins: Additional Evidence for a Common Origin J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 339 - 343. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. O'Keefe Sensitive approach: Team modernizes guidelines for managing intersex disorders AAP News, December 1, 2006; 27(12): 37 - 38. [Full Text]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
